Treatment of hepatitis C infection. Review underplayed important public health issues.
作者信息
Agarwal K, Jones D D
出版信息
BMJ. 1999 Aug 14;319(7207):450-1. doi: 10.1136/bmj.319.7207.450a.
Abstract
摘要
相似文献
1
Treatment of hepatitis C infection. Review underplayed important public health issues.丙型肝炎感染的治疗。综述未充分重视重要的公共卫生问题。
BMJ. 1999 Aug 14;319(7207):450-1. doi: 10.1136/bmj.319.7207.450a.
2
Treatment options for chronic hepatitis C infection.慢性丙型肝炎感染的治疗选择。
J Antimicrob Chemother. 1995 Oct;36(4):591-3. doi: 10.1093/jac/36.4.591-a.
3
Hepatitis C. New treatment helps some, but cure remains elusive.丙型肝炎。新的治疗方法对部分患者有帮助，但治愈仍难以实现。
FDA Consum. 1999 Mar-Apr;33(2):23-9.
4
Hepatitis C: ribavirin and/or interferon?
Rev Gastroenterol Mex. 1996 Oct-Dec;61(4 Suppl 2):S71-5.
5
Introduction: combination antiviral therapy in chronic hepatitis C.引言：慢性丙型肝炎的联合抗病毒治疗
J Hepatol. 1995;23 Suppl 2:1-2.
6
Hepatitis C recurrence in liver transplant recipients.肝移植受者丙型肝炎复发
Transplant Proc. 1997 Nov;29(7):2875-7. doi: 10.1016/s0041-1345(97)00715-x.
7
Future studies of combination therapy for chronic hepatitis C: optimizing response rates for each hepatitis C population.慢性丙型肝炎联合治疗的未来研究：优化各丙型肝炎人群的应答率
J Hepatol. 1995;23 Suppl 2:32-5; discussion 35-6.
8
Concise review of the management of hepatitis C.丙型肝炎管理的简要综述
Compr Ther. 2001 Winter;27(4):275-83. doi: 10.1007/s12019-001-0025-1.
9
[Antiviral therapy of hepatitis C].[丙型肝炎的抗病毒治疗]
Z Gastroenterol. 2000 Mar;38(3):259-69. doi: 10.1055/s-2000-14867.
10
Interferon for hepatitis C: where it has been and where it is going.丙型肝炎干扰素：过去与未来
Immunotherapy. 2013 Jul;5(7):673-5. doi: 10.2217/imt.13.55.
引用本文的文献
1
The impact of hepatitis C in general practice.丙型肝炎在全科医疗中的影响。
Br J Gen Pract. 2000 Jul;50(456):532, 535-6.
2
Refugees, asylum seekers, and general practice: room for improvement?难民、寻求庇护者与全科医疗：仍有改进空间？
Br J Gen Pract. 2000 Jul;50(456):531-2.
本文引用的文献
1
2
Hepatitis C and liver transplantation.丙型肝炎与肝移植
Gut. 1999 Aug;45(2):159-63. doi: 10.1136/gut.45.2.159.
3
4
Recent advances: hepatology.最新进展：肝病学
BMJ. 1999 May 8;318(7193):1256-9. doi: 10.1136/bmj.318.7193.1256.
5
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.干扰素α-2b单独或联合利巴韦林作为慢性丙型肝炎的初始治疗。肝炎介入治疗组。
N Engl J Med. 1998 Nov 19;339(21):1485-92. doi: 10.1056/NEJM199811193392101.
6
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT).干扰素α2b联合利巴韦林治疗48周或24周与干扰素α2b联合安慰剂治疗48周用于慢性丙型肝炎病毒感染的随机试验。国际肝炎介入治疗组（IHIT）。
Lancet. 1998 Oct 31;352(9138):1426-32. doi: 10.1016/s0140-6736(98)07124-4.
7
A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation.
Hepatology. 1998 May;27(5):1403-7. doi: 10.1002/hep.510270530.
8
Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.干扰素α与利巴韦林联合治疗肝移植后复发性丙型肝炎的初步研究。
Hepatology. 1997 Aug;26(2):500-4. doi: 10.1002/hep.510260236.
9
A pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation.利巴韦林治疗肝移植后丙型肝炎病毒复发感染的一项试点研究。
Transplantation. 1996 May 27;61(10):1483-8. doi: 10.1097/00007890-199605270-00013.
Zotero 插件